Professor of Medicine and Epidemiology and Public Health

Infectious Disease

Dr. Gerald H. Friedland, MD

Gerald Friedland is an expert in the field of Infectious Disease. He researched medicine at NYU School of Medicine. Gerald Friedland is a published MD as well. He has 47 publications published. The latest was: Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Gerald Friedland is registered with Medicare.

Publications

HIV Prevention Counseling Intervention Delivered During Routine Clinical Care Reduces HIV Risk Behavior in HIV-Infected South Africans Receiving Antiretroviral Therapy...
Investigation of the Interactions between Methadone and Elvitegravir-Cobicistat in Subjects Receiving Chronic Methadone Maintenance.
Case records of the Massachusetts General Hospital. Case 29-2013. A 32-year-old HIV-positive African man with dyspnea and skin lesions.
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.
The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone tr...
Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment.
Tipranavir/Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone.
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.
Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir.
Report from the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Early ART initiation improves survival in resource-limited settings.
Averting epidemics of extensively drug-resistant tuberculosis.
Report from the 16th Conference on Retroviruses and Opportunistic Infections. When should ART be initiated in patients with OIs?
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
Top stories of 2008. Antiretroviral rollout--successes and challenges.
Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study.
Report from the 15th Retrovirus Conference. Opportunistic infections: TB, HIV and XDR TB.
Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Further exploring the findings from SMART.
Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.
Antiretroviral treatment regimen outcomes among HIV-infected prisoners.
Report from the 14th Retrovirus Conference. Antiviral therapy outcomes: large survey highlights differences and similarities worldwide.
Opioid dependence: rationale for and efficacy of existing and new treatments.
Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Af...
HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice.
Report from the XVI International AIDS Conference. Extensively drug-resistant TB in HIV/TB-coinfected patients in rural South Africa.
Report from the XVI International AIDS Conference. Which antiretroviral regimen first? Data from CPCRA.
AIDS: the first 25 years.
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.
Report from the 13th retrovirus conference. Antiretroviral therapy in resource-limited settings.
Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients.
Meeting notes from the 3rd IAS Conference. Male circumcision: a new prevention strategy?
Meeting notes from the 3rd IAS Conference. Treating TB and HIV concurrently.
Report from the 12th Retrovirus Conference. Adherence.
Report from the 12th Retrovirus Conference. HIV/AIDS in resource-limited settings.
Report from the 12th Retrovirus Conference. Tuberculosis.
Meeting report from the XV International AIDS Conference. Access in the developing world.
Meeting report from the XV International AIDS Conference. Opportunistic infections.
Meeting report from the XV International AIDS Conference. Adherence.
Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.
Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.
Report on the XIV International AIDS Conference.
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >3...
The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.
Clinical care in the AIDS epidemic.
Chest Radiograph Findings and Time to Culture Conversion in Patients with Multidrug-Resistant Tuberculosis and HIV in Tugela Ferry, South Africa.
Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa.
Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

Schools

New York University
Bellevue Hospital Center
Beth Israel Hospital
Beth IsraelChldns Hosps Ha

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

Beth Israel Deaconess Medical Center
NYU School of Medicine

Hospital

Yale-New Haven Hospital

Drug Facts

NPI NUMBER		1174506653
NPPES Provider LastName		FRIEDLAND
NPPES Provider FirstName		GERALD
NPPES Provider ZIPCode		065103221
NPPES Provider State		CT
Specialty Description		Infectious Disease
Total Claim Count		194.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1174506653
Last Name Of The Provider	FRIEDLAND
First Name Of The Provider	GERALD
View All

Similar Doctors

	Dr. Margaret K. Fikrig, MD This Doctor is OpenDoctor Recommended.
	Dr. Merceditas S. Villanueva, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephanie H. Green, MD
	Dr. Sandra A. Springer, MD This Doctor is OpenDoctor Recommended.
	Dr. Leah A. Burke, MD This Doctor is OpenDoctor Recommended.